In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

Abstract:

:Blastic plasmacytoid dendritic cell neoplasm is an aggressive malignancy derived from plasmacytoid dendritic cells. There is currently no accepted standard of care for treating this neoplasm, and therapeutic strategies have never been prospectively evaluated. Since blastic plasmacytoid dendritic cell neoplasm cells express high levels of interleukin-3 receptor α chain (IL3-Rα or CD123), antitumor effects of the interleukin-3 receptor-targeted drug SL-401 against blastic plasmacytoid dendritic cell neoplasm were evaluated in vitro and in vivo. The cytotoxicity of SL-401 was assessed in patient-derived blastic plasmacytoid dendritic cell neoplasm cell lines (CAL-1 and GEN2.2) and in primary blastic plasmacytoid dendritic cell neoplasm cells isolated from 12 patients using flow cytometry and an in vitro cytotoxicity assay. The cytotoxic effects of SL-401 were compared to those of several relevant cytotoxic agents. SL-401 exhibited a robust cytotoxicity against blastic plasmacytoid dendritic cell neoplasm cells in a dose-dependent manner. Additionally, the cytotoxic effects of SL-401 were observed at substantially lower concentrations than those achieved in clinical trials to date. Survival of mice inoculated with a blastic plasmacytoid dendritic cell neoplasm cell line and treated with a single cycle of SL-401 was significantly longer than that of untreated controls (median survival, 58 versus 17 days, P<0.001). These findings indicate that blastic plasmacytoid dendritic cell neoplasm cells are highly sensitive to SL-401, and support further evaluation of SL-401 in patients suffering from blastic plasmacytoid dendritic cell neoplasm.

journal_name

Haematologica

journal_title

Haematologica

authors

Angelot-Delettre F,Roggy A,Frankel AE,Lamarthee B,Seilles E,Biichle S,Royer B,Deconinck E,Rowinsky EK,Brooks C,Bardet V,Benet B,Bennani H,Benseddik Z,Debliquis A,Lusina D,Roussel M,Solly F,Ticchioni M,Saas P,Garna

doi

10.3324/haematol.2014.111740

subject

Has Abstract

pub_date

2015-02-01 00:00:00

pages

223-30

issue

2

eissn

0390-6078

issn

1592-8721

pii

haematol.2014.111740

journal_volume

100

pub_type

杂志文章
  • Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia.

    abstract::The prognosis of patients with acute myeloid leukemia in whom primary treatment fails remains very poor. In order to improve such patients' outcome, we conducted a phase 2, prospective, multicenter trial to test the feasibility of a new sequential regimen, combining a short course of intensive chemotherapy and a reduc...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:10.3324/haematol.2016.150326

    authors: Mohty M,Malard F,Blaise D,Milpied N,Socié G,Huynh A,Reman O,Yakoub-Agha I,Furst S,Guillaume T,Tabrizi R,Vigouroux S,Peterlin P,El-Cheikh J,Moreau P,Labopin M,Chevallier P

    更新日期:2017-01-01 00:00:00

  • Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation.

    abstract::Pseudomonas aeruginosa is one leading gram-negative organism associated with nosocomial infections. Bacteremia is life-threatening in the immunocompromised host. Increasing frequency of multi-drug-resistant (MDRPA) strains is concerning. We started a retrospective survey in the pediatric hematology oncology Italian ne...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:10.3324/haematol.2009.020867

    authors: Caselli D,Cesaro S,Ziino O,Zanazzo G,Manicone R,Livadiotti S,Cellini M,Frenos S,Milano GM,Cappelli B,Licciardello M,Beretta C,Aricò M,Castagnola E,Infection Study Group of the Associazione Italiana Ematologia Oncologia Pediat

    更新日期:2010-09-01 00:00:00

  • Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms.

    abstract::Most DNA methylation studies in classic Philadelphia-negative myeloproliferative neoplasms have been performed on a gene-by-gene basis. Therefore, a more comprehensive methylation profiling is needed to study the implications of this epigenetic marker in myeloproliferative neoplasms. Here, we have analyzed 71 chronic ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2013.084160

    authors: Pérez C,Pascual M,Martín-Subero JI,Bellosillo B,Segura V,Delabesse E,Álvarez S,Larrayoz MJ,Rifón J,Cigudosa JC,Besses C,Calasanz MJ,Cross NC,Prósper F,Agirre X

    更新日期:2013-09-01 00:00:00

  • Immunoglobulin heavy chain and T-cell receptor beta chain gene rearrangements in acute non lymphoid leukemia.

    abstract::The occurrence of immunoglobulin heavy chain (IgH) and/or T-cell receptor (TcR) gene rearrangements has been reported in some cases of acute non lymphoid leukemia (ANLL), and variously interpreted as reflecting "aberrant gene expression" or "lineage promiscuity" of the leukemic cell. In an attempt to verify the incide...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Leone R,Lo Coco F,De Rossi G,Diverio D,Frontani M,Spadea A,Testi AM,Cordone I,Mandelli F

    更新日期:1990-03-01 00:00:00

  • Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.

    abstract:BACKGROUND:Novel therapies capable of targeting drug resistant clonogenic MM cells are required for more effective treatment of multiple myeloma. This study investigates the cytotoxicity of natural killer cell lines against bulk and clonogenic multiple myeloma and evaluates the tumor burden after NK cell therapy in a b...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2011.054254

    authors: Swift BE,Williams BA,Kosaka Y,Wang XH,Medin JA,Viswanathan S,Martinez-Lopez J,Keating A

    更新日期:2012-07-01 00:00:00

  • Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome.

    abstract::The recent identification of acquired mutations in key components of the spliceosome machinery strongly implicates abnormalities of mRNA splicing in the pathogenesis of myelodysplastic syndromes. However, questions remain as to how these aberrations functionally combine with the growing list of mutations in genes invo...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2012.075325

    authors: Mian SA,Smith AE,Kulasekararaj AG,Kizilors A,Mohamedali AM,Lea NC,Mitsopoulos K,Ford K,Nasser E,Seidl T,Mufti GJ

    更新日期:2013-07-01 00:00:00

  • Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.

    abstract::The clinical heterogeneity among first relapses of childhood ETV6/RUNX1-positive acute lymphoblastic leukemia indicates that further genetic alterations in leukemic cells might affect the course of salvage therapy and be of prognostic relevance. To assess the incidence and prognostic relevance of additional copy numbe...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2012.072470

    authors: Bokemeyer A,Eckert C,Meyr F,Koerner G,von Stackelberg A,Ullmann R,Türkmen S,Henze G,Seeger K

    更新日期:2014-04-01 00:00:00

  • ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease.

    abstract::Previous studies identified the Ser/Thr protein kinase, AKT, as a therapeutic target in thrombo-inflammatory diseases. Here we report that specific inhibition of AKT with ARQ 092, an orally-available AKT inhibitor currently in phase Ib clinical trials as an anti-cancer drug, attenuates the adhesive function of neutrop...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2016.151159

    authors: Kim K,Li J,Barazia A,Tseng A,Youn SW,Abbadessa G,Yu Y,Schwartz B,Andrews RK,Gordeuk VR,Cho J

    更新日期:2017-02-01 00:00:00

  • Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European

    abstract::Aplastic anemia is usually treated with immunosuppression or allogeneic transplant, depending on patient and disease characteristics. Syngeneic transplant offers a rare treatment opportunity with minimal transplant-related mortality, and offers an insight into disease mechanisms. We present here a retrospective analys...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2013.091074

    authors: Gerull S,Stern M,Apperley J,Beelen D,Brinch L,Bunjes D,Butler A,Ganser A,Ghavamzadeh A,Koh MB,Komarnicki M,Kröger N,Maertens J,Maschan A,Peters C,Rovira M,Sengeløv H,Socié G,Tischer J,Oneto R,Passweg J,Marsh J

    更新日期:2013-11-01 00:00:00

  • Humanized hemato-lymphoid system mice.

    abstract::Over the last decades, incrementally improved xenograft mouse models, supporting the engraftment and development of a human hemato-lymphoid system, have been developed and now represent an important research tool in the field. The most significant contributions made by means of humanized mice are the identification of...

    journal_title:Haematologica

    pub_type: 杂志文章,评审

    doi:10.3324/haematol.2014.115212

    authors: Theocharides AP,Rongvaux A,Fritsch K,Flavell RA,Manz MG

    更新日期:2016-01-01 00:00:00

  • Onset of cardiac iron loading in pediatric patients with thalassemia major.

    abstract::We reviewed cardiac T2* assessments from 77 thalassemia major patients between the ages of 2.5 and 18 years to study optimal timing of cardiac iron screening by magnetic resonance imaging. No patient under 9.5 years of age showed detectable cardiac iron in contrast to 36% of patients between the ages of 15-18 years ol...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.12513

    authors: Wood JC,Origa R,Agus A,Matta G,Coates TD,Galanello R

    更新日期:2008-06-01 00:00:00

  • Clinicopathological analysis of malignant lymphoma in Taiwan, defined according to the World Health Organization classification.

    abstract::We report the distribution and clinicopathological characteristics of malignant lymphomas in Taiwan, defined according to the WHO classification. Data including age and gender of the patients, clinical staging and disease courses were collected for 598 cases of malignant lymphomas. The results showed that the epidemio...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Lee MY,Tan TD,Feng AC,Liu MC

    更新日期:2005-12-01 00:00:00

  • Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients.

    abstract::Age is a strong prognostic factor in multiple myeloma. The overall survival is shorter in patients older than 66 years, and even shorter in those older than 75 years. Whether age is also a prognostic parameter in patients younger than 66 years treated homogeneously with intensive approaches is unknown. To address this...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2013.098608

    authors: Chretien ML,Hebraud B,Cances-Lauwers V,Hulin C,Marit G,Leleu X,Karlin L,Roussel M,Stoppa AM,Guilhot F,Lamy T,Garderet L,Pegourie B,Dib M,Sebban C,Lenain P,Brechignac S,Royer B,Wetterwald M,Legros L,Orsini-Piocelle

    更新日期:2014-07-01 00:00:00

  • Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies.

    abstract::We conducted a phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with relapsed, refractory myeloid leukemias. Twenty-eight patients received the construct intravenously at four dose levels (12, 18, 28 and 40 mg/m(2) per course) i...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2012.071092

    authors: Borthakur G,Rosenblum MG,Talpaz M,Daver N,Ravandi F,Faderl S,Freireich EJ,Kadia T,Garcia-Manero G,Kantarjian H,Cortes JE

    更新日期:2013-02-01 00:00:00

  • B-cell involvement in chronic graft-versus-host disease.

    abstract::Chronic graft-versus-host disease is a serious complication in long-term survivors of allogeneic hematopoietic stem cell transplantation, with several organ systems affected. Chronic graft-versus-host disease is an important cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation. This a...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.13311

    authors: Kapur R,Ebeling S,Hagenbeek A

    更新日期:2008-11-01 00:00:00

  • Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial.

    abstract::Arecent source data meta-analysis of randomized trials in adults assessing the immunoconjugate gemtuzumab ozogamicin combined with standard chemotherapy in acute myeloid leukemia showed a significant survival benefit in patients without an adverse karyotype. It is not clear whether the optimal dose should be 3 mg/m(2)...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.3324/haematol.2016.141937

    authors: Burnett A,Cavenagh J,Russell N,Hills R,Kell J,Jones G,Nielsen OJ,Khwaja A,Thomas I,Clark R,UK NCRI AML Study Group.

    更新日期:2016-06-01 00:00:00

  • Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.

    abstract:BACKGROUND AND OBJECTIVES:Recent progress in the development of diagnostic techniques has greatly facilitated the monitoring of minimal residual disease (MRD) in patients with chronic myeloid leukemia (CML) after allogeneic bone marrow transplantation (BMT), the only curative treatment for this disease. The presence of...

    journal_title:Haematologica

    pub_type: 杂志文章,评审

    doi:

    authors: Román J,Alvarez MA,Torres A

    更新日期:2000-10-01 00:00:00

  • A patient-oriented approach to treatment of myelodysplastic syndromes.

    abstract:BACKGROUND AND OBJECTIVE:There are several therapeutic options for patients with myeiodysplastic syndrome (MDS) but most of them are poorly effective and the potentially curative ones are available only for a minority of individuals. The aim of this article is to define a rational basis for a patient-oriented approach ...

    journal_title:Haematologica

    pub_type: 杂志文章,评审

    doi:

    authors: Cazzola M,Anderson JE,Ganser A,Hellström-Lindberg E

    更新日期:1998-10-01 00:00:00

  • Peripheral blood stem cells for allogeneic transplantation. Recommendations from the GITMO 1996. Gruppo Italiano Trapianti di Midollo Osseo.

    abstract::Allogeneic transplants with PBSC are rapidly expanding, but a number of problems concerning both donors and recipients are still unsolved. GITMO (Italian Bone Marrow Transplant Group) has established a committee for allogeneic PBSC transplants. We present here an analysis of the main aspects of this evolving area and ...

    journal_title:Haematologica

    pub_type: 指南,杂志文章

    doi:

    authors: Majolino I,Aversa F,Bacigalupo A,Bandini G,Arcese W

    更新日期:1996-11-01 00:00:00

  • Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.

    abstract:BACKGROUND AND OBJECTIVES:We tested the principle of local International Normalized Ratio (INR) calibration using INR calibrator plasmas (PT Calibration Plasma Kit, Behring), two thomboplastin reagents (Neoplastin plus, rabbit brain, Stago, and Recombiplastin, recombinant human tissue factor, Ortho Diagnostics) and the...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Testa S,Morstabilini G,Fattorini A,Galli L,Denti N,D'Angelo A

    更新日期:2002-12-01 00:00:00

  • Role of hepatocyte growth factor in the development of dendritic cells from CD34+ bone marrow cells.

    abstract:BACKGROUND AND OBJECTIVE:Hepatocyte growth factor (HGF) is known to augment the effects of stem cell factor, interleukin-3, granulocyte-macrophage colony-stimulating factor (GM-CSF), erythropoetin, and granulocyte colony-stimulating factor, all of which are involved in hematopoiesis. HGF is also known to have a role in...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Ovali E,Ratip S,Kibaroglu A,Tekelioglu Y,Cetiner M,Karti S,Aydin F,Bayik M,Akoglu T

    更新日期:2000-05-01 00:00:00

  • Hemojuvelin (HJV)-associated hemochromatosis: analysis of HJV and HFE mutations and iron overload in three families.

    abstract::Juvenile hemochromatosis is a severe form of hereditary iron overload. It can be caused by mutations in either hepcidin or hemojuvelin genes. In this study we identified the molecular basis of juvenile hemochromatosis in three Australian families and assessed the role of potential modifying genes in individuals carryi...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Wallace DF,Dixon JL,Ramm GA,Anderson GJ,Powell LW,Subramaniam N

    更新日期:2005-02-01 00:00:00

  • Immunological reconstitution in long-term survivors of thalassemia major patients after hematopoietic stem cell transplantation.

    abstract::We studied the immune function of 33 long-term survivors of thalassemia after hematopoietic stem cell transplantation. Lymphocyte subsets, lymphoproliferative response and immunoglobulin were normal but the level of natural killer cells was low. Five and seven patients had suboptimal antibody response at 4 week after ...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Li CK,Leung TF,Chan PK,Chick KW,Lee V,Cheung AY

    更新日期:2003-10-01 00:00:00

  • Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study.

    abstract:BACKGROUND:Gastrointestinal bleeding is a frequent complication of liver cirrhosis (LC) and represents an important warning sign of imminent death. Platelet dysfunction is an abnormality occurring prevalently in severe liver failure, and could well predispose to bleeding. METHODS:One hundred and two patients with live...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Violi F,Leo R,Basili S,Ferro D,Cordova C,Balsano F,CALC Group.

    更新日期:1994-01-01 00:00:00

  • IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.

    abstract:BACKGROUND:Although IFN-beta is 30-40% homologous with IFN-alpha, its intrinsic biological properties are not identical. Compared with IFN-alpha, IFN-beta exerts greater in vitro antiproliferative activity on many cell lines, stimulates peripheral blood stem cells of hairy-cell leukemia (HCL) patients to differentiate ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Liberati AM,Schippa M,Portuesi MG,Grazia Proietti M,De Angelis V,Ferrajoli A,Cinieri S,Di Clemente F,Palmisano L,Berruto P

    更新日期:1991-09-01 00:00:00

  • Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide.

    abstract::In patients with low and intermediate risk myelodysplastic syndrome and deletion 5q (del(5q)) treated with lenalidomide, monitoring of cytogenetic response is mandatory, since patients without cytogenetic response have a significantly increased risk of progression. Therefore, we have reviewed cytogenetic data of 302 p...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2010.026658

    authors: Göhring G,Giagounidis A,Büsche G,Hofmann W,Kreipe HH,Fenaux P,Hellström-Lindberg E,Schlegelberger B

    更新日期:2011-02-01 00:00:00

  • Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis.

    abstract::Perforin gene (PRF1) mutations cause the primary form of hemophagocytic lymphohistiocytosis (HLH). We report a genetic defect of PRF1 in a 62-year-old Japanese man with recurrent episodes of HLH. Sequencing of PRF1 from both peripheral blood mononuclear cells and nail clippings showed compound heterozygous mutation, i...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.11233

    authors: Nagafuji K,Nonami A,Kumano T,Kikushige Y,Yoshimoto G,Takenaka K,Shimoda K,Ohga S,Yasukawa M,Horiuchi H,Ishii E,Harada M

    更新日期:2007-07-01 00:00:00

  • Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome.

    abstract::A case of stiff-man syndrome (SMS), a rare and dramatic CNS disease characterized by continuous muscle activity and painful spasms resembling a chronic form of tetanus, occurring in a patient with Hodgkin's disease (HD) is reported. The patient developed the clinical features of SMS at the same time as the HD relapse....

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Ferrari P,Federico M,Grimaldi LM,Silingardi V

    更新日期:1990-11-01 00:00:00

  • Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.

    abstract:BACKGROUND AND OBJECTIVES:Human immunodeficiency virus (HIV) infection was transmitted to many hemophilics treated with non-inactivated factor concentrates before 1986. The aim of this study was to know the long-term incidence of AIDS and risk factors for its development in HIV-infected hemophiliacs. DESIGN AND METHOD...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Lorenzo JI,Moscardó F,López-Aldeguer J,Aznar JA

    更新日期:2001-03-01 00:00:00

  • Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia.

    abstract::Mixed lineage leukemia (MLL/KMT2A) rearrangements (MLL-r) are one of the most frequent chromosomal aberrations in acute myeloid leukemia. We evaluated the function of Meningioma 1 (MN1), a co-factor of HOXA9 and MEIS1, in human and murine MLL-rearranged leukemia by CRISPR-Cas9 mediated deletion of MN1. MN1 was require...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2018.211201

    authors: Sharma A,Jyotsana N,Gabdoulline R,Heckl D,Kuchenbauer F,Slany RK,Ganser A,Heuser M

    更新日期:2020-05-01 00:00:00